SUPRIYA LIFESCIENCE
Back to Cashflow Statement
|
SUPRIYA LIFESCIENCE Last 5 Year Cash Flow from Financing Activities History
[Standalone]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Cash Flow from Financing Activities | ₹-22 Cr | ₹-10 Cr | ₹150 Cr | ₹-15 Cr | ₹-29 Cr |
What is the latest Cash Flow from Financing Activities ratio of SUPRIYA LIFESCIENCE ?
Year | Cash Flow from Financing Activities |
---|---|
Mar2024 | ₹-22 Cr |
Mar2023 | ₹-10 Cr |
Mar2022 | ₹150 Cr |
Mar2021 | ₹-15 Cr |
Mar2020 | ₹-29 Cr |
How is Cash Flow from Financing Activities of SUPRIYA LIFESCIENCE Trending?
Years | Cash Flow from Financing Activities | % Change | |
---|---|---|---|
Mar2024 | ₹-22 Cr | Negative | |
Mar2023 | ₹-10 Cr | Negative | |
Mar2022 | ₹150 Cr | Positive | |
Mar2021 | ₹-15 Cr | Negative | |
Mar2020 | ₹-29 Cr | - |
Compare Cash Flow from Financing Activities of peers of SUPRIYA LIFESCIENCE
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
SUPRIYA LIFESCIENCE | ₹5,821.4 Cr | -2.3% | -7.1% | 136.6% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹443,145.0 Cr | -2% | 2.1% | 42.6% | Stock Analytics | |
DIVIS LABORATORIES | ₹156,280.0 Cr | -3.5% | -3.4% | 49.9% | Stock Analytics | |
CIPLA | ₹120,379.0 Cr | -2.6% | -0.6% | 17.9% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹112,701.0 Cr | -2.7% | 8.9% | 14.2% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹96,774.5 Cr | -1% | -1.7% | 36.9% | Stock Analytics |
SUPRIYA LIFESCIENCE Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
SUPRIYA LIFESCIENCE | -2.3% |
-7.1% |
136.6% |
SENSEX | -0.4% |
-3.7% |
7.9% |
You may also like the below Video Courses